MD Anderson launches neuroscience newco with $31M series A

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners (Seattle, Wash.) have co-founded Magnolia Neurosciences Corp. (New York, N.Y.), which launched Monday with a $31 million series A round.

Participating in the round were AbbVie Ventures, Alexandria Venture Investments, Arch Venture Partners, Eli Lilly and Co. (NYSE:LLY), Innovate NY Fund, J&J Innovation-JJDC Inc., Partnership Fund for New York City, Pfizer Ventures, Watson Fund, the corporate venture fund of WuXi AppTec Co. Ltd. (Shanghai:603259) and 180 Degree Capital...